首页> 外文期刊>Microbial Cell Factories >Process optimization for enhancing production of cis -4-hydroxy- l -proline by engineered Escherichia coli
【24h】

Process optimization for enhancing production of cis -4-hydroxy- l -proline by engineered Escherichia coli

机译:通过工程化大肠杆菌提高顺式-4-羟基-1-脯氨酸产量的工艺优化

获取原文
           

摘要

Understanding the bioprocess limitations is critical for the efficient design of biocatalysts to facilitate process feasibility and improve process economics. In this study, a proline hydroxylation process with recombinant Escherichia coli expressing l-proline cis-4-hydroxylase (SmP4H) was investigated. The factors that influencing the metabolism of microbial hosts and process economics were focused on for the optimization of cis-4-hydroxy-l-proline (CHOP) production. In recombinant E. coli, SmP4H synthesis limitation was observed. After the optimization of expression system, CHOP production was improved in accordance with the enhanced SmP4H synthesis. Furthermore, the effects of the regulation of proline uptake and metabolism on whole-cell catalytic activity were investigated. The improved CHOP production by repressing putA gene responsible for l-proline degradation or overexpressing l-proline transporter putP on CHOP production suggested the important role of substrate uptake and metabolism on the whole-cell biocatalyst efficiency. Through genetically modifying these factors, the biocatalyst activity was significantly improved, and CHOP production was increased by twofold. Meanwhile, to further improve process economics, a two-strain coupling whole-cell system was established to supply co-substrate (α-ketoglutarate, α-KG) with a cheaper chemical l-glutamate as a starting material, and 13.5?g/L of CHOP was successfully produced. In this study, SmP4H expression, and l-proline uptake and degradation, were uncovered as the hurdles for microbial production of CHOP. Accordingly, the whole-cell biocatalysts were metabolically engineered for enhancing CHOP production. Meanwhile, a two-strain biotransformation system for CHOP biosynthesis was developed aiming at supplying α-KG more economically. Our work provided valuable insights into the design of recombinant microorganism to improve the biotransformation efficiency that catalyzed by Fe(II)/α-KG-dependent dioxygenase.
机译:了解生物过程的局限性对于有效设计生物催化剂,促进过程的可行性和提高过程的经济性至关重要。在这项研究中,脯氨酸羟化过程与重组大肠杆菌表达l脯氨酸cis-4-羟化酶(SmP4H)进行了研究。影响微生物宿主代谢和工艺经济性的因素集中在优化顺式4-羟基-1-脯氨酸(CHOP)的生产上。在重组大肠杆菌中,观察到SmP4H合成受限。优化表达系统后,根据增强的SmP4H合成,CHOP产量得到提高。此外,研究了脯氨酸摄取和代谢调节对全细胞催化活性的影响。通过抑制负责l-脯氨酸降解的putA基因或过表达l-脯氨酸转运蛋白putP对CHOP产量的提高,提高了CHOP的产量,这表明底物摄取和代谢对全细胞生物催化剂效率的重要作用。通过对这些因素进行基因修饰,生物催化剂活性得到显着改善,CHOP产量增加了两倍。同时,为了进一步提高工艺经济性,建立了两应变耦合全细胞系统,以廉价的化学式L-谷氨酸为起始原料和13.5?g / g的共底物(α-酮戊二酸,α-KG)提供。 L CHOP已成功生产。在这项研究中,SmP4H的表达以及l-脯氨酸的摄取和降解被发现是微生物产生CHOP的障碍。因此,全细胞生物催化剂被代谢工程化以增强CHOP的产生。同时,为了更经济地供应α-KG,开发了用于CHOP生物合成的两株生物转化系统。我们的工作为重组微生物的设计提供了宝贵的见识,以提高由Fe(II)/α-KG依赖性双加氧酶催化的生物转化效率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号